The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Mounjaro Long-Term Effects — What UK Evidence Shows
Mounjaro (tirzepatide) is a prescription-only GLP-1 and GIP receptor agonist increasingly prescribed through NHS specialist weight management services in the UK. Evidence from clinical trials shows it may help support significant weight loss over extended periods, but long-term safety data is still accumulating. This guide covers what we know about sustained use, potential effects beyond clinical trials, and what NHS guidance recommends for ongoing monitoring and use.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
What Clinical Trials Reveal About Long-Term Mounjaro Use
The SURMOUNT clinical trial programme tracked tirzepatide over 72 weeks, showing an average weight loss of approximately 15–21% of body weight depending on dose — roughly comparable to results from semaglutide (Wegovy) studies. However, 72 weeks is medium-term, not genuinely long-term.
Key findings from available evidence:
- Weight loss generally stabilises by around week 26–32 on a stable dose
- Continuing the medication appears necessary to maintain weight loss — stopping often leads to weight regain
- The most common long-term side effect is nausea, which tends to improve as the body adjusts over weeks or months
- Gastrointestinal side effects (constipation, diarrhoea) may persist but often become manageable
- Injection site reactions are usually mild and temporary
- Blood sugar control remains improved in people with type 2 diabetes or prediabetes
Real-world data from NHS specialist services and private prescribing is still limited — Mounjaro became available in the UK relatively recently, so genuine long-term follow-up beyond 12 months remains uncommon in published research.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
NHS Monitoring and Long-Term Safety Considerations
The NHS requires ongoing monitoring while taking tirzepatide. If you're prescribed Mounjaro through an NHS tier 3 specialist weight management service, you'll typically have regular appointments to assess weight progress, side effects, and overall health impact. Your GP should also be informed and involved in monitoring.
Points to discuss with your prescriber:
- Whether to continue indefinitely or stop after reaching a target weight
- The risk of weight regain if you stop treatment
- Monitoring for pancreatitis symptoms (severe stomach pain)
- Changes in appetite or any persistent side effects
- Impact on other medications, especially those affecting blood sugar
- The need for periodic blood tests to check kidney function and metabolic markers
Use our free BMI calculator to track your current status, and consider our progress tracker to log changes over time alongside medical appointments.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Does Mounjaro cause permanent long-term damage if used for years?
Current evidence suggests no — tirzepatide has been studied for up to 2 years in clinical trials with a good safety profile. However, truly long-term data (5+ years) does not yet exist. Ongoing monitoring by your prescriber is essential to catch any unexpected effects early.
What happens to weight loss if I stop Mounjaro after long-term use?
Weight regain is common when stopping tirzepatide. Most people gradually regain weight over weeks to months unless they maintain strict diet and exercise changes. Many specialists recommend continuing treatment to sustain benefits, though this is an individual decision made with your prescriber.
Can I take Mounjaro long-term safely while managing type 2 diabetes?
Yes — tirzepatide is used both for weight management and diabetes control. In fact, long-term use may help improve blood sugar stability. Your diabetes medications may need adjustment as you lose weight, so regular monitoring with your GP is important.
Does Mounjaro lose effectiveness over time?
The "tolerance" question remains unclear from current data. Some patients report stable weight loss maintenance on the same dose for 12+ months, while others may need dose adjustments. Your prescriber will assess whether your dose remains effective during long-term use.
How often should I have check-ups while taking Mounjaro long-term?
NHS guidance typically recommends assessments every 3–6 months when stable, with blood pressure, weight, and symptom checks. Private prescribers usually require check-ins at least every 6 months. More frequent appointments may be needed initially during dose titration phases.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.